Avrobio Inc reported $220.99M in Equity Capital and Reserves for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Akebia Therapeutics AKBA:US $ 174.63M 39.26M
Alnylam Pharmaceuticals ALNY:US $ 853.36M 72.83M
Applied Genetic Technologies AGTC:US $ 85.81M 11.19M
Bluebird Bio BLUE:US $ 984.56M 215.77M
Epizyme EPZM:US $ 67.63M 55.4M
Gilead Sciences GILD:US $ 19710M 758M
Intercept Pharmaceuticals ICPT:US $ -203.2M 3.2M
Karyopharm Therapeutics KPTI:US $ -83132000 43.49M
Macrogenics MGNX:US $ 319.04M 31.49M
Sangamo Biosciences SGMO:US $ 445.46M 24.9M
Sarepta Therapeutics SRPT:US $ 485.11M 50.34M
Takeda 4502:JP Y 5299774M 126737M